Induction of arginase ii mRNA by nitric oxide using an in vitro model of gyrate atrophy of choroid and retina

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 3, 2011, Pages 1493-1500

  Ohnaka, Masayuki ^a   Okuda Ashitaka, Emiko ^b   Kaneko, Shiho ^a   Ando, Akira ^a   Maeda, Masahide ^c   Furuta, Kyoji ^c   Suzuki, Masaaki ^c   Takahashi, Kanji ^a   Ito, Seiji ^b  

^a Departments of Ophthalmology   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 FLUOROMETHYLORNITHINE; ARGINASE; ARGINASE 2; ARGININE; ENZYME INHIBITOR; MESSENGER RNA; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; S (2 BORONOETHYL)CYSTEINE; S NITROSOGLUTATHIONE; SMALL INTERFERING RNA; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ARGININE METABOLISM; ARTICLE; CHOROID GYRATE ATROPHY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA GYRATE ATROPHY; UPREGULATION;

ANIMALS; ARGINASE; BORONIC ACIDS; CELL LINE; ENZYME INHIBITORS; GYRATE ATROPHY; HUMANS; MODELS, BIOLOGICAL; NITRIC OXIDE; ORNITHINE; RETINAL PIGMENT EPITHELIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; SWINE; TETRAZOLIUM SALTS; THIAZOLES; UP-REGULATION;

EID: 79955938800     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5516     Document Type: Article

References (39)

1. Valle D, Simell O. The hyperornithinemias. In: Scriver C, Beaudet A, Sly W, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York: McGraw-Hill; 1995:1147-1185.
2. Wang T, Milam AH, Steel G, Valle D. A mouse model of gyrate atrophy of the choroid and retina: early retinal pigment epithelium damage and progressive retinal degeneration. J Clin Invest. 1996; 97:2753-2762.
3. Simell O, Takki K. Raised plasma-ornithine and gyrate atrophy of the choroid and retina. Lancet. 1973;1:1031-1033.
4. Valle D, Walser M, Brusilow SW, Kaiser-Kupfer M. Gyrate atrophy of the choroid and retina: amino acid metabolism and correction of hyperornithinemia with an arginine-deficient diet. J Clin Invest. 1980;65:371-378.
5. Kaiser-Kupfer MI, de Monasterio FM, Valle D, Walser M, Brusilow S. Gyrate atrophy of the choroid and retina: improved visual function following reduction of plasma ornithine by diet. Science. 1980;210:1128-1131.
6. Kaiser-Kupfer MI, Caruso RC, Valle D. Gyrate atrophy of the choroids and retina: long-term reduction of ornithine slows retinal degeneration. Arch Ophthalmol. 1991;109:1539-1548.
7. Wang T, Steel G, Milam AH, Valle D. Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina. Proc Natl Acad Sci USA. 2000;97:1224-1229.
8. Hayasaka S, Shiono T, Takaku Y, Mizuno K. Ornithine ketoacid aminotransferase in the bovine eye. Invest Ophthalmol Vis Sci. 1980;19:1457-1460.
9. Rao GN, Cotlier E. Ornithine delta-aminotransferase activity in retina and other tissues. Neurochem Res. 1984;9:555-562.
10. Ueda M, Masu Y, Ando A, et al. Prevention of ornithine cytotoxicity by proline in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1998;39:820-827.
11. Kaneko S, Ando A, Okuda-Ashitaka E, et al. Ornithine transport via cationic amino acid transporter-1 is involved in ornithine cytotoxicity in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2007;48:464-471.
12. Kaneko S, Okuda-Ashitaka E, Ando A, et al. Polyamines upregulate the mRNA expression of cationic amino acid transporter-1 in human retinal pigment epithelial cells. Am J Physiol Cell Physiol. 2007;293:C729-C737.
13. Hatzoglou M, Fernandez J, Yaman I, Closs E. Regulation of cationic amino acid transport: the story of the CAT-1 transporter. Annu Rev Nutr. 2004;24:377-399.
14. Closs EI, Boissel JP, Habermeier A, Rotmann A. Structure and function of cationic amino acid transporters (CATs). J Membr Biol. 2006;213:67-77.
15. Nakauchi T, Ando A, Ueda-Yamada M, et al. Prevention of ornithine cytotoxicity by nonpolar side chain amino acids in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2003;44:5023-5028.
16. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998;336:1-17.
17. Morris SM Jr. Arginine: beyond protein. Am J Clin Nutr. 2006;83: 508S-512S.
18. Morris SM Jr. Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharmacol. 2009;157:922-930.
19. Goureau O, Lepoivre M, Becquet F, Courtois Y. Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation. Proc Natl Acad Sci USA. 1993;90:4276-4280.
20. Koga T, Zhang WY, Gotoh T, et al. Induction of citrulline-nitric oxide (NO) cycle enzymes and NO production in immunostimulated rat RPE-J cells. Exp Eye Res. 2003;76:15-21.
21. Li R, Maminishkis A, Banzon T, et al. IFN_ regulates retinal pigment epithelial fluid transport. Am J Physiol Cell Physiol. 2009;297: C1452-C1465.
22. Koshiyama Y, Gotoh T, Miyanaka K, et al. Expression and localization of enzymes of arginine metabolism in the rat eye. Curr Eye Res. 2000;20:313-321.
23. Rambhata L, Chiu CP, Glickman RD, Rowe-Rendeleman C. In vitro differentiation capacity of telomerase immortalized human RPE cells. Invest Ophthalmol Vis Sci. 2002;43:1622-1630.
24. Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982; 126:131-138.
25. Demougeot C, Prigent-Tessier A, Bagnost T, et al. Time course of vascular arginase expression and activity in spontaneously hypertensive rats. Life Sci. 2007;80:1128-1134.
26. Johnson FK, Johnson RA, Peyton KJ, Durante W. Arginase inhibition restores arteriolar endothelial function in Dahl rats with saltinduced hypertension. Am J Physiol Regul Integr Comp Physiol. 2005;288:R1057-R1062.
27. Xu W, Kaneko FT, Zheng S, et al. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J. 2004;18:1746-1748.
28. Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ, Champion HC. Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun. 2001;283:923-927.
29. Ryoo S, Gupta G, Benjo A, et al. Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res. 2008;102: 923-932.
30. Salimuddin, Nagasaki A, Gotoh T, Isobe H, Mori M. Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide. Am J Physiol. 1999;277: E110-E117.
31. Gotoh T, Mori M. Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells. J Cell Biol. 1999;144:427-434.
32. Marathe C, Bradley MN, Hong C, et al. The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages. J Biol Chem. 2006;281:32197-32206.
33. Grandvaux N, Gaboriau F, Harris J, et al. Regulation of arginase II by interferon regulatory factor 3 and the involvement of polyamines in the antiviral response. FEBS Lett J. 2005;272:3120 -3131.
34. Wei LH, Morris SM Jr, Cederbaum SD, Mori M, Ignarro LJ. Induction of arginase II in human Caco-2 tumor cells by cyclic AMP. Arch Biochem Biophys. 2000;374:255-260.
35. Bogdan C. Nitric oxide and the regulation of gene expression. Trends Cell Biol. 2001;11:66 -75.
36. Pfeilschifter J, Eberhardt W, Beck KF. Regulation of gene expression by nitric oxide. Eur J Physiol. 2001;442:479-486.
37. Mori M. Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling. J Nutr. 2007;137:1616S-1620S.
38. Santhanam L, Christianson DW, Nyhan D, Berkowitz DE. Arginase and vascular aging. J Appl Physiol. 2008;105:1632-1642.
39. Li H, Meininger CJ, Hawker JR Jr, et al. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab. 2001;280: E75-E82.